Liom extends Series A to €40.8M for needle-free glucose tech

Liom raises €13.9M to push needle-free glucose monitoring Liom, a Swiss health-tech startup developing a calibration-free, needle-free glucose monitoring wearable, has raised €13.9 million to extend its Series A round to €40.8 million. The company says the additional capital will…









